Total debt jumped to $4.5B in Q3 2026, pushing D/E to 48.76, while shareholders' equity turned negative at -$67M, signaling severe financial strain.
| Metric | TTM | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 | Jun'96 |
|---|
| Total Current Assets | 2.65B | 1.61B | 1.62B | 1.83B | 1.73B | 1.83B | 2.02B | 1.3B | 1.31B | 1.51B | 1.49B | 1.43B | 1.4B | 1.42B | 1.38B | 1.28B | 1.12B | 1.18B | 1.25B | 1.03B | 1.01B | 1.09B | 1.04B | 951M | 1B | 1.1B | 1.45B | 1.12B | 798.7M | 673.5M | 573.8M |
| Cash & Short-Term Investments | 1.19B | 167M | 202M | 367M | 183M | 319M | 871M | 111M | 131M | 418M | 401M | 382M | 329M | 299M | 267M | 259M | 87M | 206M | 214M | 182M | 192M | 293M | 232M | 172M | 177M | 251M | 245M | 132M | 89.7M | 101M | 90.8M |
| Cash Only | 1.19B | 167M | 202M | 367M | 183M | 319M | 871M | 111M | 131M | 418M | 401M | 382M | 329M | 299M | 267M | 259M | 87M | 206M | 214M | 182M | 192M | 293M | 232M | 172M | 177M | 251M | 245M | 132M | 89.7M | 101M | 90.8M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 671M | 821M | 695M | 688M | 681M | 604M | 648M | 631M | 600M | 565M | 569M | 519M | 546M | 580M | 576M | 525M | 540M | 486M | 505M | 460M | 435M | 411M | 460M | 463M | 483M | 514M | 633M | 610M | 428.5M | 357M | 315.1M |
| Days Sales Outstanding | 38.69 | 42.18 | 35.76 | 33.99 | 34.97 | 30.03 | 35.19 | 37.06 | 35.76 | 34.53 | 36.05 | 33.5 | 36.14 | 37.65 | 38.45 | 36.63 | 37.66 | 32.55 | 34.96 | 34.64 | 34.19 | 34.19 | 38.83 | 40.78 | 43.41 | 48.07 | 56.59 | 55.62 | 57.05 | 51.45 | 51.86 |
| Inventory | 588M | 523M | 637M | 696M | 755M | 752M | 454M | 512M | 506M | 459M | 443M | 385M | 386M | 394M | 384M | 382M | 367M | 366M | 384M | 309M | 292M | 323M | 301M | 264M | 258M | 281M | 376M | 319M | 211.9M | 170.3M | 138.8M |
| Days Inventory Outstanding | 55.19 | 49.06 | 57.48 | 56.69 | 60.41 | 66.27 | 45.3 | 53.61 | 53.55 | 50.74 | 51.19 | 43.97 | 44.44 | 44.66 | 44.09 | 46.99 | 46.1 | 43.46 | 45.48 | 40.85 | 39.62 | 47.21 | 46.03 | 43.31 | 40.8 | 44.23 | 66.98 | 65.3 | 73.32 | 62.34 | 56.88 |
| Other Current Assets | 205M | 97M | 88M | 77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 104M | 92M | 106M | 106M | 113M | 530M | 122M | 150M | 81M | 88M | 63M | 50M | 52M | 134M | 57M | 200M | 55M | 91M | 45.2M | 29.1M |
| Total Non-Current Assets | 3.79B | 3.95B | 4.13B | 4.12B | 4.43B | 4.5B | 4.19B | 3.81B | 3.75B | 3.06B | 3.03B | 2.73B | 2.86B | 2.89B | 2.98B | 2.88B | 3.43B | 3.4B | 3.46B | 2.63B | 2.61B | 2.53B | 2.79B | 2.7B | 2.63B | 2.89B | 2.9B | 3.02B | 2.23B | 2.1B | 1.61B |
| Property, Plant & Equipment | 1.59B | 1.6B | 1.68B | 1.69B | 1.68B | 1.63B | 1.39B | 1.03B | 996M | 931M | 906M | 918M | 977M | 1.02B | 1.08B | 1.04B | 979M | 955M | 960M | 976M | 1B | 999M | 1.05B | 1.07B | 922M | 1.05B | 1.08B | 1.05B | 596.3M | 570.6M | 551.4M |
| Fixed Asset Turnover | 4.24x | 4.44x | 4.23x | 4.37x | 4.24x | 4.49x | 4.82x | 6.01x | 6.15x | 6.42x | 6.36x | 6.16x | 5.64x | 5.51x | 5.06x | 5.03x | 5.35x | 5.71x | 5.49x | 4.97x | 4.63x | 4.39x | 4.11x | 3.87x | 4.40x | 3.73x | 3.78x | 3.80x | 4.60x | 4.44x | 4.02x |
| Goodwill | 1.23B | 1.23B | 1.23B | 1.25B | 1.56B | 1.57B | 1.58B | 1.59B | 1.6B | 1.2B | 1.2B | 1.07B | 1.1B | 1.1B | 1.11B | 1.07B | 1.65B | 1.63B | 1.66B | 855M | 744M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 49M | 566M | 681M | 712M | 884M | 918M | 894M | 912M | 929M | 722M | 735M | 585M | 611M | 627M | 642M | 633M | 646M | 662M | 683M | 348M | 604M | 599M | 1.38B | 1.38B | 1.3B | 1.57B | 1.54B | 1.5B | 1.52B | 1.19B | 704.7M |
| Long-Term Investments | 171M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 746M | 558M | 545M | 462M | 315M | 378M | 328M | 274M | 222M | 210M | 187M | 165M | 174M | 138M | 144M | 142M | 144M | 149M | 158M | 186M | 257M | 186M | 364M | 248M | 306M | 272M | 284M | 465M | 442M | 346.9M | 349M |
| Total Assets | 6.44B | 5.56B | 5.75B | 5.95B | 6.16B | 6.33B | 6.21B | 5.12B | 5.06B | 4.57B | 4.52B | 4.16B | 4.26B | 4.31B | 4.36B | 4.16B | 4.55B | 4.58B | 4.71B | 3.67B | 3.62B | 3.62B | 3.83B | 3.65B | 3.63B | 4B | 4.35B | 4.13B | 3.03B | 2.78B | 2.18B |
| Asset Turnover | 1.17x | 1.28x | 1.23x | 1.24x | 1.15x | 1.16x | 1.08x | 1.21x | 1.21x | 1.31x | 1.28x | 1.36x | 1.29x | 1.30x | 1.26x | 1.26x | 1.15x | 1.19x | 1.12x | 1.32x | 1.28x | 1.21x | 1.13x | 1.13x | 1.12x | 0.98x | 0.94x | 0.97x | 0.90x | 0.91x | 1.02x |
| Asset Growth % | 14.67% | -3.3% | -3.26% | -3.46% | -2.78% | 1.95% | 21.44% | 1.11% | 10.65% | 1.22% | 8.5% | -2.21% | -1.23% | -1.01% | 4.61% | -8.61% | -0.46% | -2.8% | 28.42% | 1.38% | -0.03% | -5.66% | 4.98% | 0.61% | -9.14% | -8.22% | 5.35% | 36.37% | 9.07% | 27.5% | 14.28% |
| Total Current Liabilities | 3.15B | 1.92B | 1.57B | 1.92B | 1.78B | 2.06B | 1.42B | 1.44B | 1.2B | 1.81B | 1.56B | 1.41B | 1.64B | 1.13B | 2.06B | 1.36B | 1.65B | 1.94B | 1.66B | 1.43B | 1.13B | 1.35B | 1.27B | 1.45B | 1.23B | 1.07B | 1.54B | 1.37B | 1.23B | 892.7M | 623.9M |
| Accounts Payable | 1.48B | 838M | 950M | 1.02B | 960M | 930M | 575M | 507M | 507M | 501M | 490M | 431M | 440M | 413M | 412M | 423M | 409M | 381M | 418M | 329M | 329M | 347M | 310M | 312M | 330M | 314M | 378M | 206M | 226M | 143.4M | 155.4M |
| Days Payables Outstanding | 149.06 | 78.61 | 85.72 | 83.17 | 76.81 | 81.95 | 57.37 | 53.09 | 53.65 | 55.38 | 56.62 | 49.22 | 50.66 | 46.82 | 47.3 | 52.04 | 51.37 | 45.24 | 49.5 | 43.49 | 44.64 | 50.72 | 47.4 | 51.18 | 52.19 | 49.42 | 67.34 | 42.17 | 78.2 | 52.49 | 63.68 |
| Short-Term Debt | 1.59B | 4M | 4M | 50M | 237M | 300M | 0 | 396M | 199M | 804M | 523M | 395M | 718M | 202M | 1.15B | 459M | 671M | 998M | 755M | 574M | 308M | 361M | 291M | 574M | 332M | 319M | 773M | 741M | 778M | 373.5M | 193M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 179M | 190M | 262M | 176M | 219M | 288M | 158M | 154M | 162M | 192M | 189M | 119M | 155M | 165M | 0 | 0 | 0 | 0 | 17M | 19M | 26M | 24M | 28M | 54M | 0 | 36M | 421M | 377M | 375.8M | 275.5M |
| Current Ratio | 0.84x | 0.84x | 1.03x | 0.95x | 0.97x | 0.89x | 1.42x | 0.91x | 1.09x | 0.84x | 0.95x | 1.02x | 0.85x | 1.25x | 0.67x | 0.94x | 0.68x | 0.61x | 0.75x | 0.72x | 0.89x | 0.81x | 0.82x | 0.66x | 0.82x | 1.03x | 0.94x | 0.82x | 0.65x | 0.75x | 0.92x |
| Quick Ratio | 0.65x | 0.57x | 0.63x | 0.59x | 0.54x | 0.52x | 1.10x | 0.55x | 0.67x | 0.58x | 0.67x | 0.74x | 0.62x | 0.90x | 0.48x | 0.66x | 0.46x | 0.42x | 0.52x | 0.51x | 0.63x | 0.57x | 0.59x | 0.47x | 0.61x | 0.77x | 0.70x | 0.58x | 0.48x | 0.56x | 0.70x |
| Cash Conversion Cycle | -55.18 | 12.63 | 7.52 | 7.51 | 18.57 | 14.35 | 23.12 | 37.59 | 35.66 | 29.88 | 30.62 | 28.25 | 29.92 | 35.5 | 35.23 | 31.59 | 32.38 | 30.77 | 30.93 | 32 | 29.17 | 30.68 | 37.45 | 32.91 | 32.03 | 42.87 | 56.23 | 78.75 | 52.18 | 61.3 | 45.06 |
| Total Non-Current Liabilities | 3.19B | 3.16B | 3.69B | 3.64B | 3.65B | 3.69B | 3.89B | 3.12B | 3.13B | 2.22B | 2.66B | 2.64B | 2.47B | 3.03B | 2.43B | 2.88B | 2.83B | 2.81B | 3.42B | 2.07B | 2.64B | 2.82B | 1.03B | 986M | 1.05B | 1.03B | 1.02B | 1.19B | 719.8M | 849.3M | 622.2M |
| Long-Term Debt | 2.49B | 2.48B | 2.48B | 2.48B | 2.47B | 2.48B | 2.78B | 2.29B | 2.28B | 1.39B | 1.79B | 1.8B | 1.59B | 2.17B | 1.57B | 2.13B | 2.12B | 2.15B | 2.72B | 1.46B | 1.97B | 2.12B | 475M | 495M | 678M | 685M | 590M | 702M | 704M | 565.9M | 356.3M |
| Capital Lease Obligations | 1.25B | 305M | 334M | 310M | 314M | 301M | 278M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 82M | 20M | 22M | 28M | 66M | 67M | 62M | 50M | 72M | 61M | 82M | 95M | 103M | 119M | 119M | 140M | 24M | 23M | 97M | 90M | 129M | 82M | 174M | 115M | 142M | 147M | 224M | 237M | 200.4M | 170.7M | 148.4M |
| Other Non-Current Liabilities | 356M | 351M | 848M | 825M | 791M | 834M | 767M | 780M | 778M | 770M | 784M | 750M | 768M | 742M | 739M | 619M | 677M | 640M | 632M | 516M | 547M | 618M | 377M | 376M | 231M | 194M | 204M | 255M | 228M | 112.7M | 117.5M |
| Total Liabilities | 6.34B | 5.08B | 5.26B | 5.56B | 5.43B | 5.74B | 5.3B | 4.56B | 4.33B | 4.03B | 4.22B | 4.05B | 4.1B | 4.17B | 4.49B | 4.25B | 4.47B | 4.75B | 5.08B | 3.5B | 3.77B | 4.17B | 2.29B | 2.44B | 2.28B | 2.1B | 2.56B | 2.56B | 1.94B | 1.74B | 1.25B |
| Total Debt | 4.49B | 2.88B | 2.9B | 2.92B | 3.1B | 3.17B | 3.12B | 2.68B | 2.48B | 2.19B | 2.31B | 2.19B | 2.31B | 2.37B | 2.72B | 2.58B | 2.79B | 3.15B | 3.48B | 2.04B | 2.27B | 2.48B | 766M | 1.07B | 1.01B | 1B | 1.36B | 1.44B | 1.48B | 939.4M | 549.3M |
| Net Debt | 3.3B | 2.71B | 2.7B | 2.56B | 2.92B | 2.85B | 2.25B | 2.57B | 2.35B | 1.78B | 1.91B | 1.81B | 1.98B | 2.07B | 2.45B | 2.33B | 2.71B | 2.94B | 3.26B | 1.85B | 2.08B | 2.19B | 534M | 897M | 833M | 753M | 1.11B | 1.31B | 1.38B | 838.4M | 458.5M |
| Debt / Equity | 48.76x | 5.98x | 5.90x | 7.54x | 4.26x | 5.35x | 3.44x | 4.80x | 3.42x | 4.05x | 7.78x | 18.57x | 15.02x | 16.25x | - | - | 33.67x | - | - | 11.91x | - | - | 0.50x | 0.88x | 0.75x | 0.53x | 0.76x | 0.92x | 1.37x | 0.91x | 0.59x |
| Debt / EBITDA | 3.49x | 2.06x | 3.03x | 2.76x | 3.29x | 2.20x | 2.17x | 2.08x | 1.92x | 1.71x | 1.88x | 1.87x | 2.03x | 2.09x | 2.58x | 2.41x | 2.40x | 2.56x | 3.17x | 1.93x | 2.28x | 2.51x | 0.72x | 1.02x | 1.07x | 1.20x | 1.39x | 1.64x | 2.19x | 1.58x | 1.03x |
| Net Debt / EBITDA | 2.57x | 1.94x | 2.82x | 2.41x | 3.10x | 1.98x | 1.56x | 2.00x | 1.82x | 1.39x | 1.55x | 1.54x | 1.74x | 1.82x | 2.33x | 2.16x | 2.32x | 2.39x | 2.97x | 1.76x | 2.09x | 2.21x | 0.50x | 0.86x | 0.88x | 0.90x | 1.13x | 1.49x | 2.04x | 1.41x | 0.86x |
| Interest Coverage | 11.19x | 13.25x | 5.42x | 3.64x | 6.73x | 10.09x | 12.97x | 11.56x | 13.40x | 12.74x | 12.99x | 10.69x | 9.93x | 8.17x | 7.43x | 5.58x | 6.79x | 6.04x | 5.13x | 7.58x | 6.14x | 10.23x | - | - | - | - | - | - | - | - | - |
| Total Equity | 92M | 482M | 492M | 388M | 729M | 592M | 908M | 559M | 726M | 542M | 297M | 118M | 154M | 146M | -135M | -86M | 83M | -175M | -370M | 171M | -156M | -553M | 1.54B | 1.22B | 1.35B | 1.9B | 1.79B | 1.57B | 1.09B | 1.04B | 932.8M |
| Equity Growth % | -163.08% | -2.03% | 26.8% | -46.78% | 23.14% | -34.8% | 62.43% | -23% | 33.95% | 82.49% | 151.69% | -23.38% | 5.48% | 208.15% | -56.98% | -203.61% | 147.43% | 52.7% | -316.37% | 209.62% | 71.79% | -135.91% | 26.75% | -10.27% | -28.74% | 5.91% | 14.27% | 44.67% | 4.75% | 11.06% | -1.18% |
| Book Value per Share | 0.76 | 3.88 | 3.94 | 3.12 | 5.88 | 4.65 | 7.11 | 4.31 | 5.52 | 4.12 | 2.25 | 0.89 | 1.17 | 1.10 | -1.02 | -0.62 | 0.59 | -1.24 | -2.61 | 1.11 | -1.02 | -3.09 | 7.18 | 5.51 | 5.77 | 7.93 | 7.49 | 6.54 | 5.23 | 4.92 | 4.51 |
| Total Shareholders' Equity | -67M | 321M | 328M | 220M | 556M | 411M | 908M | 559M | 726M | 542M | 297M | 118M | 154M | 146M | -135M | -86M | 83M | -175M | -370M | 171M | -156M | -553M | 1.54B | 1.22B | 1.35B | 1.9B | 1.79B | 1.57B | 1.09B | 1.04B | 932.8M |
| Common Stock | 131M | 131M | 131M | 131M | 131M | 131M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 250M | 250M | 250M | 250M | 250M | 250M | 250M | 250M | 0 | 0 | 0 |
| Retained Earnings | 223M | 432M | 250M | 583M | 1.05B | 1.04B | 3.57B | 3.15B | 2.8B | 2.44B | 2.16B | 1.92B | 1.74B | 1.56B | 1.35B | 1.14B | 920M | 640M | 386M | 185M | 3.94B | 3.68B | 2.85B | 2.56B | 2.27B | 2.14B | 2.07B | 1.84B | 1.38B | 1.21B | 1.08B |
| Treasury Stock | -1.58B | -1.4B | -1.19B | -1.25B | -1.35B | -1.4B | -3.31B | -3.19B | -2.66B | -2.44B | -2.32B | -2.24B | -2.04B | -1.87B | -1.88B | -1.77B | -1.24B | -1.21B | -1.27B | -445M | -4.53B | -4.46B | -1.57B | -1.51B | -1.07B | -441M | -451M | -392M | -392M | 0 | 0 |
| Accumulated OCI | -152M | -157M | -155M | -493M | -479M | -546M | -640M | -602M | -547M | -543M | -570M | -502M | -417M | -367M | -396M | -250M | -371M | -347M | -179M | -209M | -215M | -352M | -287M | -348M | -318M | -246M | -200M | -180M | -612.4M | -474.8M | -409.8M |
| Minority Interest | 159M | 161M | 164M | 168M | 173M | 181M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
High leverage and negative equity
Total debt jumped from $2.9B to $4.5B in Q3 2026, while equity turned negative at -$67M, pushing D/E to 48.76, per recent quarterly filings.
The balance sheet has deteriorated sharply in the latest quarter, with debt increasing by over $1.3B sequentially and equity swinging from positive to negative. This suggests the company may have taken on significant new borrowing, possibly to fund operations or cover cash shortfalls, given the negative free cash flow reported in the same period. The negative equity position, if sustained, could signal accumulated losses or aggressive capital returns, and it materially raises financial risk.
Debt-to-equity spiked to 48.76 in Q3 2026 from 5.98 in Q4 2025, as total debt rose to $4.5B, according to balance sheet data.
The dramatic increase in leverage appears to be a recent development, possibly tied to the aftermath of the cyberattack or working capital needs. With equity negative, the D/E ratio becomes less meaningful, but the absolute debt level is high relative to the company's asset base. This may constrain future borrowing capacity and increase interest expense, which could pressure earnings, especially if rates remain elevated.
Total assets grew to $6.4B in Q3 2026, with goodwill steady at $1.2B and PPE at $1.6B, as per the latest balance sheet.
The asset mix remains consistent, with goodwill and intangibles representing a significant portion of total assets. While no impairment has been recorded recently, the VMS segment's underperformance could warrant future write-downs. PPE has remained flat, suggesting limited new investment, which aligns with the subdued capex intensity observed in cash flow statements.
Shareholders' equity turned negative at -$67M in Q3 2026, down from $321M in Q4 2025, based on reported balance sheet figures.
The swing to negative equity is a critical development, driven by a sharp decline in retained earnings to $223M from $432M, likely reflecting substantial losses or dividend payments exceeding earnings. This may indicate that the company is funding dividends and buybacks with debt, which is unsustainable in the long run. Investors should monitor whether management plans to restore positive equity through earnings retention or capital raises.
Cash surged to $1.2B in Q3 2026, but the current ratio fell to 0.84, indicating potential short-term obligations exceed liquid assets, per SEC filings.
Despite a large cash balance, the current ratio remains below 1, suggesting that current liabilities have grown faster than current assets. This could be due to increased short-term debt or payables. The cash position provides a buffer, but the negative working capital implies reliance on ongoing financing or operational cash flow to meet near-term obligations.
The reported D/E of 5.98 in Q4 2025 appears anomalous given the historical range of 12-92, per balance sheet data, potentially understating leverage.
The extreme volatility in D/E, from 5.98 to 91.91 within a few quarters, suggests that equity is near zero, making the ratio highly sensitive to small changes. This distortion can mislead investors about the company's actual leverage. A more stable measure, such as debt-to-assets, shows debt at 70% of assets in Q3 2026, which is more informative. The negative equity also raises questions about the sustainability of the dividend and the company's ability to absorb further shocks.
Quick answers to the most common questions about buying CLX stock.
As of 2025, The Clorox Company (CLX) had total assets of $5.56B including $1.61B in current assets.
The Clorox Company (CLX) carries total debt of $2.88B, offset by $167.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
The Clorox Company (CLX) has total shareholders' equity (book value) of $321.0M ($3.88 book value per share). Book value represents the net worth of the company belonging to common stock holders.
The Clorox Company (CLX) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.